Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014

被引:19
|
作者
Guan, Qi [4 ]
Khuu, Wayne [2 ]
Spithoff, Sheryl [5 ]
Kiran, Tara [1 ,2 ,7 ]
Kahan, Meldon [7 ]
Tadrous, Mina [1 ,2 ,4 ]
Martins, Diana [2 ]
Leece, Pamela [3 ,5 ,7 ]
Gomes, Tara [1 ,2 ,4 ,6 ]
机构
[1] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada
[2] Inst Clin Evaluat Sci, Vet Hill Trail,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada
[3] Publ Hlth Ontario, Suite 300,480 Univ Ave, Toronto, ON M5G 1V2, Canada
[4] Univ Toronto, Leslie Dan Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada
[5] Womens Coll Hosp, 76 Grenville St, Toronto, ON M5S 1B2, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, 155 Coll St, Toronto, ON M5T 3M6, Canada
[7] Univ Toronto, Dept Family & Community Med, 500 Univ Ave, Toronto, ON M5G 1V7, Canada
基金
加拿大健康研究院;
关键词
Methadone; Buprenorphine; Opioid prescribing; Opioid agonist treatment; Opioid use disorder; GINI COEFFICIENT; USE DISORDERS; BUPRENORPHINE; METHADONE; THERAPY; MANAGEMENT; ABSTINENCE; RETENTION; PROGRAMS;
D O I
10.1016/j.drugalcdep.2017.05.002
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Despite concerns surrounding high patient volumes in methadone clinics, little is known about the practice patterns of opioid maintenance therapy (OMT) providers in Ontario. We examined the distribution of these services and how physician characteristics differ based on prescribing volume. Methods: We conducted a cross-sectional study among prescribers of methadone or buprenorphine to Ontario public drug beneficiaries in 2014 by stratifying physicians into low- (lower 50%), moderate- (51-89%) and high volume (top 10%) prescribers. We summarized the distribution of OMT prescription days dispensed and urine drug screens (UDS) ordered using Lorenz curves and examined physician characteristics using descriptive statistics. Results: We identified 893 OMT prescribers in 2014. Physicians were mostly male (67.5%; N = 603), and middle-aged (median was 50). High-volume methadone providers (N = 57) prescribed approximately 56% (N = 4,115,322) of the total days of methadone (Gini coefficient = 0.76, 95% CI 0.74-0.79) while high-volume buprenorphine providers (N = 64) prescribed 61% (N = 589,463) of the total days of buprenorphine (Gini coefficient = 0.78, 95% CI 0.75-0.80). On average, each high-volume methadone prescriber treated 435 OMT patients and billed 43 UDS per patient, while each high-volume buprenorphine prescriber treated 64 OMT patients and billed 22 UDS per patient. Daily OMT patient volume was on average 74 for high-volume methadone prescribers and 6 for high-volume buprenorphine prescribers. Conclusions: OMT services are highly concentrated among a small portion of OMT providers who carry high daily patient volumes. Future research should examine the quality of primary care received by their patients to better elucidate the possible consequences of this highly unequal distribution of services.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 50 条
  • [1] The Cost of Providing Methadone Maintenance Treatment in Ontario, Canada
    Zaric, Gregory S.
    Brennan, Andrew W.
    Varenbut, Michael
    Daiter, Jeff M.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2012, 38 (06) : 559 - 566
  • [2] Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework
    Tahsin, Farah
    Morin, Kristen A.
    Vojtesek, Frank
    Marsh, David C.
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [3] Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
    Reimer, Jens
    Vogelmann, Tobias
    Truemper, Daniel
    Scherbaum, Norbert
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2019, 14 (01)
  • [4] Sleeping Patterns in Patients with Opioid Use Disorder: Effects of Opioid Maintenance Treatment and Detoxification
    Chrobok, Agnieszka I.
    Krause, Daniela
    Winter, Catja
    Ploerer, Diana
    Martin, Gabriele
    Koller, Gabriele
    Adorjan, Kristina
    Canolli, Minavere
    Adam, Roland
    Wagner, Elias M.
    Peles, Einat
    Paul, Dietmar
    Vogel, Thomas
    Pogarell, Oliver
    JOURNAL OF PSYCHOACTIVE DRUGS, 2020, 52 (03) : 203 - 210
  • [5] Pain management in opioid maintenance treatment
    Koller, Gabi
    Schwarzer, Andreas
    Halfter, Kathrin
    Soyka, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (16) : 1993 - 2005
  • [6] Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012-2018
    Krebs, Emanuel
    Homayra, Fahmida
    Min, Jeong E.
    MacDonald, Sue
    Gold, Leila
    Carter, Connie
    Nosyk, Bohdan
    DRUG AND ALCOHOL DEPENDENCE, 2021, 225
  • [7] A regional approach to reduce postoperative opioid prescribing in Ontario, Canada
    Jackson, Timothy D.
    Maeda, Azusa
    Beath, Tricia
    Ahmad, Nancy
    Price-Arsenault, Pierrette
    Jia, Hui
    Lam, Jonathan
    Schramm, David
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2022, 34 (04)
  • [8] Opioid Agonist Treatment Retention Among People Initiating Methadone and Buprenorphine Across Diverse Demographic and Geographic Subgroups in Ontario: A Population-based Retrospective Cohort Study
    Elnagdi, Abdulrahman
    McCormack, Daniel
    Bozinoff, Nikki
    Tadrous, Mina
    Antoniou, Tony
    Munro, Charlotte
    Campbell, Tonya
    Paterson, J. Michael
    Mamdani, Muhammad
    Sproule, Beth
    Gomes, Tara
    CANADIAN JOURNAL OF ADDICTION, 2023, 14 (04) : 44 - 54
  • [9] Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada
    Iacono, Anita
    Wang, Tianru
    Tadrous, Mina
    Campbell, Tonya
    Kolla, Gillian
    Sproule, Beth
    Kleinman, Robert A.
    Besharah, Jes
    Munro, Charlotte
    Doolittle, Mccaffrey
    Gomes, Tara
    DRUG AND ALCOHOL DEPENDENCE, 2024, 254
  • [10] Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment
    Jens Reimer
    Tobias Vogelmann
    Daniel Trümper
    Norbert Scherbaum
    Substance Abuse Treatment, Prevention, and Policy, 14